# Maze Therapeutics, Inc. (MAZE) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Maze Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MAZE/mda/fy2025/): filed 2026-03-25; accession 0001193125-26-122778 (https://www.sec.gov/Archives/edgar/data/1842295/000119312526122778/maze-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/MAZE/mda/fy2024/): filed 2025-03-31; accession 0000950170-25-047208 (https://www.sec.gov/Archives/edgar/data/1842295/000095017025047208/maze-10k-2024.htm)

Back to /company/MAZE/